Skip to main content
. 2017 Oct 11;12(10):e0186073. doi: 10.1371/journal.pone.0186073

Table 4. Expression of SLAMF4 on peripheral blood T and B lymphocytes, monocytes and on T cell differentiated subsets on healthy donors and patients with SLE.

SLAMF4
Healthy Donors (n = 12–22) SLE patients (n = 14–25) p valueb
Mean (%)a SEM Mean (%) SEM
CD4 5.0 1.4 3.6 1.9 0.925
CD8 56.4 2.6 45.1 3.7 0.025
DNT 77.2 4.3 55.7 5.0 0.0000020
B cells 0.6 0.1 0.2 0.1 0.944
Monocytes 99.0 0.3 95.3 2.2 0.856
CD4+ T cells
Naïve 1.1 0.4 0.9 0.3 1.000
CM 1.3 0.3 1.2 0.4 1.000
EM 11.7 2.4 5.0 1.6 0.232
CD8+ T cells
Naïve 2.5 0.9 2.3 0.8 1.000
CM 48.4 3.9 37.8 4.4 0.014
EM 85.8 2.4 75.7 4.4 0.020
TDEM 93.2 1.7 88.6 2.6 0.563

a Results are expressed as mean percentage (%) ± SEM.

b p values ≤ 0.05 are considered statistically significant